Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:42 AM UTC
| NCT Number | NCT05197270 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | PHASE1 |
| Target Enrollment | 215 participants |
| Active Locations | 25 sites in the US |
| Sponsor | 4D Molecular Therapeutics |
| Last Updated on CT.gov | August 21, 2026 (Aug 21, 2026) |
As of October 17, 2026: Clinical trial NCT05197270 is currently recruiting participants. This phase1 study for macular degeneration is actively seeking new participants at 25 locations across the United States. The study is sponsored by 4D Molecular Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05197270 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05197270 was last updated Aug 21, 2026 (August 21, 2026). HelloStudys verifies this status automatically.